Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
HYPAQUE™-76(Diatrizoate Meglumine and Diatrizoate Sodium Injection, USP)76%
Medication labelWhy this: Advisory · dailymed-prescription
HYPAQUE-76 is indicated for excretory urography, aortography, angiocardiography (ventriculography, pulmonary angiography, selective coronary arteriography), peripheral angiography (peripheral arteriography and peripheral venography), intravenous digital arteriography, contrast enhancement of computed tomographic head imaging, contrast enhancement of computed tomographic body imaging, selective renal arteriography, selective visceral arteriography, central venography, and renal venography. In addition to the following generalCONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS, there are additional listings in these categories under the particular procedures.
- generic_name
- diatrizoate meglumine and diatrizoate sodium
- brand_name
- HYPAQUE, Diatrizoate Meglumine, Diatrizoate, Diatrizoate Sodium
- product_names
- Diatrizoate Meglumine and Diatrizoate Sodium, HYPAQUE, Diatrizoate Meglumine, Diatrizoate, Diatrizoate Sodium
- ndc
- 0407-0776, 0407-0776-04, 0407-0778, 0407-0778-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en